| UPSA Switzerland AG - Dafalgan DOLO 500 mg, Brausetabletten | | 69265 | | 01 | | Dafalgan DOLO 500 mg | | Brausetabletten | | N02BE01 | | Paracetamol | | 01.05.2024 | | |
| | Composition | | paracetamolum 500 mg, acidum citricum, natrii hydrogenocarbonas, natrii carbonas, sorbitolum 126.1 mg, E 211 50 mg, aromatica (Grapefruit/Orange) cum glucosum 0.83 mg et fructosum 0.96 mg et saccharum 0.28 mg, saccharinum natricum, povidonum K 30, natrii docusas, pro compresso corresp. natrium 197 mg. | | Packungsbestandteile | | Effervescent tablets | | | | Active Agent | Dose |
|---|
| Paracetamol | 500 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Citric Acid | | | | Aromatica (Grapefruit/orange) cum Glucosum | 0.83 mg | | | E 211 | 50 mg | conserv. | | Fructosum | 0.96 mg | | | Sodium Carbonate | | | | Natrii Docusas | | | | Sodium Hydrogen Carbonate | | | | Povidonum K | 30 | | | Pro Compresso | | | | Saccharinum Natricum | | | | Saccharum | 0.28 mg | | | Sorbitol | 126.1 mg | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 16 | PR | PR | D | | No |
|
|
